Page last updated: 2024-10-27

fenfluramine and Apnea, Sleep

fenfluramine has been researched along with Apnea, Sleep in 2 studies

Fenfluramine: A centrally active drug that apparently both blocks serotonin uptake and provokes transport-mediated serotonin release.
fenfluramine : A secondary amino compound that is 1-phenyl-propan-2-amine in which one of the meta-hydrogens is substituted by trifluoromethyl, and one of the hydrogens attached to the nitrogen is substituted by an ethyl group. It binds to the serotonin reuptake pump, causing inhbition of serotonin uptake and release of serotonin. The resulting increased levels of serotonin lead to greater serotonin receptor activation which in turn lead to enhancement of serotoninergic transmission in the centres of feeding behavior located in the hypothalamus. This suppresses the appetite for carbohydrates. Fenfluramine was used as the hydrochloride for treatment of diabetes and obesity. It was withdrawn worldwide after reports of heart valve disease and pulmonary hypertension.

Research Excerpts

ExcerptRelevanceReference
"Obesity is a morbid condition with hemodynamic consequences affecting the systemic and pulmonary circulations leading to a risk of pulmonary hypertension."2.41[Pulmonary hypertension and obesity]. ( Humbert, M; Ioos, V; Parent, F; Simonneau, G; Sitbon, O; Sztrymf, B, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeMeo, MT1
Mobarhan, S1
Mikolaitis, S1
Kazi, N1
Sztrymf, B1
Ioos, V1
Sitbon, O1
Parent, F1
Simonneau, G1
Humbert, M1

Reviews

1 review available for fenfluramine and Apnea, Sleep

ArticleYear
[Pulmonary hypertension and obesity].
    Revue de pneumologie clinique, 2002, Volume: 58, Issue:2

    Topics: Aminorex; Fenfluramine; Hemodynamics; Humans; Hypertension, Pulmonary; Hypothyroidism; Hypoxia; Obes

2002

Other Studies

1 other study available for fenfluramine and Apnea, Sleep

ArticleYear
Three cases of comprehensive dietary therapy and pharmacotherapy of patients with complex obesity-related diseases.
    Nutrition reviews, 1997, Volume: 55, Issue:8

    Topics: Adult; Aged; Appetite Depressants; Diabetes Mellitus, Type 2; Diet, Reducing; Fatty Liver; Female; F

1997